Life Science Connect ( “LSC”) is pleased to announce the appointment of Will Rompala as Chief Technology Officer. With more than 25 years of senior leadership experience, Mr. Rompala joins LSC to lead a comprehensive organizational transformation that includes technology, product and process enhancements. LSC is a portfolio company of Latticework Capital Management and Edgehill Management.

LSC, headquartered in Pittsburgh, Pennsylvania, is an intelligent, data-driven platform designed for B2B connection, collaboration and contribution. As a leader in digital media for the life sciences, LSC is committed to enhancing professional connections within the sector to accelerate research, development, manufacturing and the application of scientific innovations.

Mr. Rompala brings more than two decades of experience in data science, advertising intelligence, software engineering and organizational change to his role as CTO. Before joining LSC, he held CTO roles at Health Union and Sidecar, where he applied machine learning and data-driven strategies. Mr. Rompala’s career includes leadership positions at Kantar Media, where he led a global organization of hundreds across 14 countries as well as all software engineering across North America, and at companies such as PointRoll, iPipeline, Corviant Corporation and JP Morgan, where he built and managed technology teams and developed innovative systems. Mr. Rompala's expertise spans creating large-scale patient communities, leveraging data to optimize business processes, and driving technological advancements across industries, all of which will lend itself to the strategic growth of LSC.

“I am incredibly energized to join Life Science Connect at such a pivotal moment,” said Mr. Rompala. “I’m most excited about transforming our data into a true strategic asset, optimizing our product delivery processes, and aligning our technology stack to directly accelerate our mission. This is about building the engine that will allow us to help professionals discover market opportunities faster and ultimately make a tangible impact on the advancement of life-saving therapies and devices.”

“This hire goes beyond technology; it’s about a comprehensive operational and product overhaul," said Jon Howland, CEO. “Will is a change architect with a proven ability to build scalable, reliable systems and to create and lead highly performing teams. His experience in implementing product-led transformations and positive change highlights the kind of impact we expect across our entire organization.”

Mr. Rompala’s strategic focus will include key areas vital to LSC’s future:

• Data and Analytics: Design and develop an integrated enterprise data architecture, similar to what they created at Health Union, which opened new revenue streams. This effort will utilize advanced analytics, identity resolution, and machine learning to convert raw data into a critical business asset.
• Operational Excellence: His skills in applying OKR frameworks and implementing Agile methodologies will be key to refining engineering and product development practices. This will promote a more predictable, scalable, and dependable delivery process.
• Strategic Leadership: With broad experience in M&A, due diligence, and managing multi-million dollar technology budgets, he will ensure technology investments align with business goals.

This appointment underscores LSC’s commitment to leveraging technology as a key driver of business success, positioning the company to fulfill its mission of advancing life-changing therapies and devices.

LSC is actively seeking acquisition and growth opportunities to help expand their suite of capabilities for B2B sales and marketing enablement and to reach new audiences. Please contact Jon Howland (jon.howland@lifescienceleader.com) to connect further regarding a potential acquisition.

About Life Science Connect

Life Science Connect is a network of life science go-to-work solutions dedicated to a better way of connecting professionals across life science communities to advance the pace of research, development, manufacturing, and use of life science innovations. Life Science Connect facilitates mutually beneficial connections between audiences and strategic partners that accelerate the advancement of life-improving, life-extending, and life-saving therapies and devices. LSC serves a loyal, professional readership that demands original, compelling content with professional applications and facilitates engagement across the drug development lifecycle through leading digital publications, events, podcasts, and more. To learn more visit www.lifescienceconnect.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251016472077/en/